May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
3M Stock: Dividend Likely Cut In Half
Amazon Q1 Review: Best Of Big Tech Bunch
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Cortexyme (CRTX) stock forecast for 2026
Updated: May 2, 2024 (03:27)
Sector: HealthcareThe share price of Cortexyme, Inc. (CRTX) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Cortexyme stocks, the 50-day moving average is the support level today.
For Cortexyme stocks, the 200-day moving average is the support level today.
Are you interested in Cortexyme, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Cortexyme stock price in 2026. How much will one Cortexyme share be worth in 2026? Is it worth taking profit / loss on CRTX stock now or waiting? What are analysts' forecasts for Cortexyme stock?
We forecast Cortexyme stock performance using neural networks based on historical data on CRTX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Cortexyme, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Cortexyme analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Cortexyme, Inc. stock
The chart below shows the historical price of Cortexyme stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRTX stock price can be found in the table below.
Cortexyme, Inc., a clinical stage biopharmaceutical company, specializes in the development of therapeutics for the treatment of Alzheimer’s disease and other degenerative diseases. Its main drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule inhibitor of gingipain, which is in phase II/III clinical trials for use in patients with mild to moderate Alzheimer’s disease. Cortexyme Inc. is a partner of the Parkinson Study Group.
Cortexyme (CRTX) Forecast for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.60 | 1.46 | 1.74 | 15.81 % |
Feb | 1.67 | 1.47 | 1.84 | 20.11 % |
Mar | 1.67 | 1.40 | 1.73 | 19.04 % |
Apr | 1.70 | 1.57 | 1.82 | 13.51 % |
May | 1.67 | 1.50 | 1.79 | 16.39 % |
Jun | 1.69 | 1.45 | 1.82 | 20.19 % |
Jul | 1.89 | 1.81 | 2.08 | 13.07 % |
Aug | 2.07 | 1.75 | 2.15 | 18.65 % |
Sep | 2.07 | 1.95 | 2.28 | 14.70 % |
Oct | 1.93 | 1.70 | 2.05 | 17.11 % |
Nov | 1.92 | 1.72 | 2.15 | 20.18 % |
Dec | 1.89 | 1.74 | 2.06 | 15.62 % |
Cortexyme information and performance
N/A
Market capitalization of the Cortexyme, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRTX shares in the company outstanding by the market price of one share.
EBITDA of Cortexyme is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Cortexyme price target for 2026 by month
Target values for the price of one Cortexyme share for Jan 2026.
In Jan, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 15.809% volatility is expected.
Pessimistic target level: 1.46
Optimistic target level: 1.74
Target values for the price of one Cortexyme share for Feb 2026.
In Feb, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 20.109% volatility is expected.
Pessimistic target level: 1.47
Optimistic target level: 1.84
Target values for the price of one Cortexyme share for Mar 2026.
In Mar, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 19.038% volatility is expected.
Pessimistic target level: 1.40
Optimistic target level: 1.73
Target values for the price of one Cortexyme share for Apr 2026.
In Apr, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 13.508% volatility is expected.
Pessimistic target level: 1.57
Optimistic target level: 1.82
Target values for the price of one Cortexyme share for May 2026.
In May, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 16.387% volatility is expected.
Pessimistic target level: 1.50
Optimistic target level: 1.79
Target values for the price of one Cortexyme share for Jun 2026.
In Jun, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 20.186% volatility is expected.
Pessimistic target level: 1.45
Optimistic target level: 1.82
Target values for the price of one Cortexyme share for Jul 2026.
In Jul, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 13.067% volatility is expected.
Pessimistic target level: 1.81
Optimistic target level: 2.08
Target values for the price of one Cortexyme share for Aug 2026.
In Aug, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 18.654% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 2.15
Target values for the price of one Cortexyme share for Sep 2026.
In Sep, the Positive dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 14.701% volatility is expected.
Pessimistic target level: 1.95
Optimistic target level: 2.28
Target values for the price of one Cortexyme share for Oct 2026.
In Oct, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 17.105% volatility is expected.
Pessimistic target level: 1.70
Optimistic target level: 2.05
Target values for the price of one Cortexyme share for Nov 2026.
In Nov, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 20.179% volatility is expected.
Pessimistic target level: 1.72
Optimistic target level: 2.15
Target values for the price of one Cortexyme share for Dec 2026.
In Dec, the Negative dynamics for Cortexyme, Inc. shares will prevail with possible monthly volatility of 15.625% volatility is expected.
Pessimistic target level: 1.74
Optimistic target level: 2.06
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.